Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Variable Rate Preferred Invesco ETF (VRP)

Variable Rate Preferred Invesco ETF (VRP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 1,968,290,000
  • Shares Outstanding, K 74,500
  • 60-Month Beta 0.48
Trade VRP with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 1.11 (4.19%)
  • Most Recent Dividend 0.090 on 08/23/21
  • Management Fee 0.50%
  • Sectors:

    ETFs - Mixed Asset

Options Overview

Details
  • Implied Volatility 3.59%
  • Historical Volatility 1.94%
  • IV Percentile 25%
  • IV Rank 2.38%
  • IV High 132.92% on 04/06/21
  • IV Low 0.44% on 05/27/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.21 +0.92%
on 08/23/21
26.50 -0.19%
on 09/03/21
+0.03 (+0.11%)
since 08/17/21
3-Month
26.20 +0.95%
on 06/21/21
26.50 -0.19%
on 09/03/21
+0.18 (+0.69%)
since 06/17/21
52-Week
24.22 +9.21%
on 09/24/20
26.50 -0.19%
on 09/03/21
+1.53 (+6.14%)
since 09/17/20

Most Recent Stories

More News
Preferred ETF (VRP) Hits New 52-Week High

The preferred ETF VRP hit a new 52-week high lately. Can it soar further?

VRP : 26.45 (+0.08%)
Invesco Announces Changes to Two ETFs

, /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global asset management firm, announced today that it will change the underlying indexes of two exchange-traded funds (ETFs) in its line-up: the...

PGF : 19.18 (+0.10%)
VRP : 26.45 (+0.08%)
IVZ : 26.25 (+5.46%)
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020

Initiated ENHANCE Phase 3 clinical trials in COPD

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update

Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its unaudited financial results...

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will present new analyses from a Phase 2b clinical...

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of a pilot study to investigate the efficacy...

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference

Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and...

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020

Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will present new subgroup analysis from Phase...

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD

Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of the second, multiple dose, part of...

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020

Completed $200 million private placement post period

VRP : 26.45 (+0.08%)
VRNA : 5.75 (+4.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Invesco Variable Rate Preferred ETF is based on the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The Fund will generally invest at least 90% of its total assets in preferred securities that comprise the Index. The Index is a market capitalization-weighted index designed...

See More

Top 10 Holdings

Name % Holdings
N/A 2.23%
N/A 1.42%
N/A 1.26%
N/A 1.17%
N/A 1.12%
N/A 1.11%
N/A 1.09%
N/A 1.08%
N/A 1.07%
N/A 1.04%

See More

Key Turning Points

3rd Resistance Point 26.52
2nd Resistance Point 26.50
1st Resistance Point 26.48
Last Price 26.45
1st Support Level 26.44
2nd Support Level 26.42
3rd Support Level 26.40

See More

52-Week High 26.50
Last Price 26.45
Fibonacci 61.8% 25.63
Fibonacci 50% 25.36
Fibonacci 38.2% 25.09
52-Week Low 24.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar